Peritoneal Dialysis Fluid Bioincompatibility and New Vessel Formation Promote Leukocyte‐Endothelium Interactions in a Chronic Rat Model for Peritoneal Dialysis

Microcirculation (2010) 17, 271–280. doi: 10.1111/j.1549‐8719.2010.00024.x

[1]  J. van den Born,et al.  Factors Contributing to Peritoneal Tissue Remodeling in Peritoneal Dialysis , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[2]  H. Bitterman,et al.  Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation. , 2009, Translational research : the journal of laboratory and clinical medicine.

[3]  Klaus Ley,et al.  Mechanisms and consequences of neutrophil interaction with the endothelium. , 2008, The American journal of pathology.

[4]  R. Saracho,et al.  Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  S. Yung,et al.  Studying the Effects of New Peritoneal Dialysis Solutions on the Peritoneum , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[6]  A. Wieslander,et al.  Improvement of Peritoneal Ultrafiltration with Peritoneal Dialysis Solution Buffered with Bicarbonate/Lactate Mixture , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  C. Schalkwijk,et al.  Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  D. Oreopoulos,et al.  Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions , 2006, International Urology and Nephrology.

[9]  C. Schalkwijk,et al.  Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  N. Lameire,et al.  Effects of New Peritoneal Dialysis Solutions on Leukocyte Recruitment in the Rat Peritoneal Membrane , 2005, Nephron Experimental Nephrology.

[11]  S. Sela,et al.  Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[12]  Yeong-Hoon Kim,et al.  Superior Patient Survival for Continuous Ambulatory Peritoneal Dialysis Patients Treated with a Peritoneal Dialysis Fluid with Neutral pH and Low Glucose Degradation Product Concentration (Balance) , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[13]  J. van den Born,et al.  Effect of fixation protocols on in situ detection of L-selectin ligands. , 2005, Journal of immunological methods.

[14]  J. van den Born,et al.  Better Preservation of the Peritoneum in Rats Exposed to Amino Acid-Based Peritoneal Dialysis Fluid , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  F. Bazargani.  Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms. , 2005, Swedish dental journal. Supplement.

[16]  David W. Johnson,et al.  Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  B. Grabensee,et al.  Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  J. van den Born,et al.  The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions. , 2003, Kidney international. Supplement.

[19]  C. Schalkwijk,et al.  Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  C. Hoff.  In vitro biocompatibility performance of Physioneal. , 2003, Kidney international. Supplement.

[21]  J. Nagy,et al.  Mesothelial Cell Transplantation in Models of Acute Inflammation and Chronic Peritoneal Dialysis , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[22]  N. Lameire,et al.  Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. , 2003, Journal of the American Society of Nephrology : JASN.

[23]  P. Iversen,et al.  Macrophage‐dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat , 2002, European journal of haematology.

[24]  J. van den Born,et al.  Increased Leukocyte Rolling in Newly Formed Mesenteric Vessels in the Rat during Peritoneal Dialysis , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[25]  J. van den Born,et al.  Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. , 2001, Journal of the American Society of Nephrology : JASN.

[26]  A. M. Lefer,et al.  Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. , 2001, American journal of physiology. Endocrinology and metabolism.

[27]  A. Christensson,et al.  Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. , 2001, Kidney international.

[28]  B. Lindholm,et al.  Biocompatibility of New Peritoneal Dialysis Solutions: Clinical Experience , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[29]  R. Gokal.  Peritoneal Dialysis , 2000, Drugs & aging.

[30]  K. Ateş,et al.  The Longitudinal Effect of a Single Peritonitis Episode on Peritoneal Membrane Transport in CAPD Patients , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  D. Vestweber,et al.  Mechanisms that regulate the function of the selectins and their ligands. , 1999, Physiological reviews.

[32]  R. Beelen,et al.  Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis. , 1998, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[33]  T. Golper,et al.  Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. , 1997, Kidney international.

[34]  N. Topley.  Biocompatibility of peritoneal dialysis solutions and host defense. , 1996, Advances in renal replacement therapy.

[35]  U. Frei,et al.  Peritoneal dialysis fluid biocompatibility: does it really matter? , 1994, Kidney international. Supplement.

[36]  D. Granger,et al.  Modulation of leukocyte migration in mesenteric interstitium. , 1994, The American journal of physiology.

[37]  M Intaglietta,et al.  Microvascular measurements by video image shearing and splitting. , 1973, Microvascular research.